Search - tctmd.com

Displaying 561 - 580 of 675

Sort: Relevancy | Date

Presentation TCT 2016

Device Specifications and Clinical Program Update: Desyne BD

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Biomime

Presenter: Alexandre Abizaid, Ashok Seth

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Alex

Presenter: Alexandre Abizaid, Ashok Seth, Dariusz Dudek

October 31, 2016

Presentation TCT 2016

Device and Clinical Program Highlights: Abluminus

Presenter: Alexandre Abizaid, Ashok Seth, Dinesh Shah

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES!

Presenter: Stephan Windecker, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Presenter: Stephan Windecker, Michael Joner

October 31, 2016

Presentation TCT 2016

Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences?

Presenter: Stephan Windecker, Julinda Mehilli

October 31, 2016

Presentation TCT 2016

Potential Advantages and Pitfalls of Bioabsorbable Polymers

Presenter: Stephan Windecker, Renu Virmani

October 31, 2016

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

Advertisement

Device Specifications and Clinical Program Update: Desyne BD

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Device Specifications and Clinical Program Update: Biomime

Device Specifications and Clinical Program Update: Alex

Device and Clinical Program Highlights: Abluminus

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES!

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences?

Potential Advantages and Pitfalls of Bioabsorbable Polymers

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content